Form 4: InfuSystem Holdings Director Paul Gendron Reports Stock Option Grant

Paul Gendron, a director at InfuSystem Holdings, reported the acquisition of stock options and the disposal of common stock.

Summary

• Paul Andrew Gendron, a director of InfuSystem Holdings, Inc., filed a Form 4 with the SEC.
• The report details changes in his beneficial ownership of the company's securities.
• On May 16, 2025, Gendron acquired options to purchase 39,588 shares of InfuSystem Holdings common stock at an exercise price of $6.
• These options vest on May 16, 2026, and expire on May 16, 2035.
• Gendron also disposed of 65,000 shares of common stock.
• Following these transactions, Gendron directly owns 39,588 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The disposal of shares could be seen as slightly negative, but the acquisition of options balances this out.

Negatives

• Paul Gendron disposed of 65,000 shares of common stock.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in the director's holdings, which can be interpreted in various ways by the market.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in publicly traded companies, including those in the healthcare sector like InfuSystem Holdings.
• The vesting schedule and exercise price are typical components of such grants, designed to align the interests of executives with those of shareholders.
• Comparing the size of the grant and the exercise price to those of similar companies (e.g., Option Care Health, BioLife Solutions) would provide further context.

Stakeholder Impact

• Shareholders may interpret the director's transactions as a signal of confidence or lack thereof in the company's future prospects.
• The option grant aligns the director's interests with those of shareholders, incentivizing him to increase the company's value.

Key Dates

Keywords

Form 4, InfuSystem Holdings, Beneficial Ownership, Stock Options, Gendron, Director